1496P - IO-synthesise NSCLC: A pooled analysis of real-world survival outcomes for non-small cell lung cancer patients treated with nivolumab in France and Germany

Autor: Dixmier 1, Asselain, B. 2, Barlesi, F. 3, Debieuvre, D. 4, Valette, C Audigier 5, Gröschel, A. 6, Gütz, S. 7, Liersch, R. 8, Moro-Sibilot, D. 9, Müller-Huesmann, H. 10, Perol, M. 11, Raspaud, C. 12, Schulte, C. 13, Schulz, H. 14, Schumann, C. 15, Allan, V. 16, Calvet, C.Y. 17, Rothnie, K.J. 18, Wünsch, V. 19, Sebastian, M. 20
Zdroj: In Annals of Oncology October 2019 30 Supplement 5:v614-v614
Databáze: ScienceDirect